Evidence map›Paper›PMID 40964044›Full record

ArticleResearch square2025

Autophagy Upregulation in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma Uncovers a Novel Therapeutic Target.

Felipe J Núñez, Kaushik Banerjee, Anzar A Mujeeb, Ava Mauser, Claire E Tronrud, Ziwen Zhu, Sadhakshi Raghuram, Maya R Sheth, Jorge Armando Pena Agudelo, Julio Zelaya and 19 more

Abstract readPreprint
PubMed Full text at PMC Publisher
In one paragraph

Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors.

Felipe J NúñezDepartment of Neurosurgery, University of Michigan Medical School; Ann Arbor, MI 48109, USA.
Kaushik BanerjeeDepartment of Neurosurgery, University of Michigan Medical School; Ann Arbor, MI 48109, USA.
Anzar A MujeebDepartment of Neurosurgery, University of Michigan Medical School; Ann Arbor, MI 48109, USA.
Ava MauserDepartments of Chemical Engineering, Material Science and Engineering, Biomedical Engineering, and Macromolecular Science and Engineering, University of Michigan; Ann Arbor, MI 48109, USA.
Claire E TronrudDepartment of Neurosurgery, University of Michigan Medical School; Ann Arbor, MI 48109, USA.
Ziwen ZhuDepartment of Neurosurgery, University of Michigan Medical School; Ann Arbor, MI 48109, USA.
Sadhakshi RaghuramDepartment of Neurosurgery, University of Michigan Medical School; Ann Arbor, MI 48109, USA.
Maya R ShethDepartment of Neurosurgery, University of Michigan Medical School; Ann Arbor, MI 48109, USA.
Jorge Armando Pena AgudeloDepartment of Neurosurgery, University of Michigan Medical School; Ann Arbor, MI 48109, USA.
Julio ZelayaDepartments of Chemical Engineering, Material Science and Engineering, Biomedical Engineering, and Macromolecular Science and Engineering, University of Michigan; Ann Arbor, MI 48109, USA.
Ayman TaherDepartment of Neurosurgery, University of Michigan Medical School; Ann Arbor, MI 48109, USA.
Padma KadiyalaDepartment of Neurosurgery, University of Michigan Medical School; Ann Arbor, MI 48109, USA.
Stephen V CarneyDepartment of Neurosurgery, University of Michigan Medical School; Ann Arbor, MI 48109, USA.
Maria B Garcia-FabianiDepartment of Neurosurgery, University of Michigan Medical School; Ann Arbor, MI 48109, USA.
Andrea CombaDepartment of Neurosurgery, University of Michigan Medical School; Ann Arbor, MI 48109, USA.ORCID https://orcid.org/0000-0002-3398-5753
Mahmoud S AlghamriDepartment of Neurosurgery, University of Michigan Medical School; Ann Arbor, MI 48109, USA.
Brandon L McClellanDepartment of Neurosurgery, University of Michigan Medical School; Ann Arbor, MI 48109, USA.
Zeribe C NwosuRogel Cancer Center, University of Michigan; Ann Arbor, MI 48109, USA.
Hanna S HongRogel Cancer Center, University of Michigan; Ann Arbor, MI 48109, USA.
Peter SajjakulnukitDepartment of Internal Medicine, Division of Gastroenterology, University of Michigan; Ann Arbor, MI 48109, USA.ORCID https://orcid.org/0000-0002-8556-7481
Tingting QinDepartment of Computational Medicine and Bioinformatics, University of Michigan; Ann Arbor, MI 48109, USA.
Maureen A SartorDepartment of Computational Medicine and Bioinformatics, University of Michigan; Ann Arbor, MI 48109, USA.ORCID https://orcid.org/0000-0001-6155-5702
Mats LjungmanDepartment of Radiation Oncology, University of Michigan; Ann Arbor, MI 48109, USA.ORCID https://orcid.org/0000-0003-1553-6695
Joshua D WelchDepartment of Computational Medicine and Bioinformatics, University of Michigan; Ann Arbor, MI 48109, USA.
Shi-Yuan ChengKen & Ruth Davee Department of Neurology, Northwestern University, Feinberg School of Medicine; Chicago IL 60611, USA.ORCID https://orcid.org/0000-0003-1737-0588
Pedro R LowensteinDepartment of Neurosurgery, University of Michigan Medical School; Ann Arbor, MI 48109, USA.
Joerg LahannDepartments of Chemical Engineering, Material Science and Engineering, Biomedical Engineering, and Macromolecular Science and Engineering, University of Michigan; Ann Arbor, MI 48109, USA.ORCID https://orcid.org/0000-0002-3334-2053
Costas A LyssiotisRogel Cancer Center, University of Michigan; Ann Arbor, MI 48109, USA.ORCID https://orcid.org/0000-0001-9309-6141
Maria G CastroDepartment of Neurosurgery, University of Michigan Medical School; Ann Arbor, MI 48109, USA.ORCID https://orcid.org/0000-0003-2237-2756

Funding

XenograftP30CA046592 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Eric R. Fearon · 1988 to 2026
$178.2M
Immune-suppressive Myeloid Cells in the Glioma Microenvironment: Signaling Mechanisms and Novel Therapeutic StrategiesR37NS094804 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CASTRO, MARIA G · 2015 to 2021
$2.9M
3-D spatial approach to discover genomic effectors of immunosuppression during malignant transformationR01CA244838 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COSTELLO, JOSEPH F · 2020 to 2024
$2.7M
Systemic Delivery of Targeted Bi-Compartmental Nanoparticles for Glioblastoma Therapeutics (Supplement)R01NS124167 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Maria G Castro, JOERG LAHANN · 2022 to 2026
$2.6M
Uncover the role of H3.3-G343R mutation in shaping the DNA damage response, anti-tumor immunity and mechanisms of resistance in glioma.R01NS122165 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Maria G Castro · 2022 to 2026
$2.5M
The Role of Collagen and its Signaling Mechanisms in Glioma Progression and Invasion.R01NS122234 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Pedro R. Lowenstein · 2022 to 2026
$2.4M
Stromal metabolism promotes therapeutic resistance in pancreatic cancerR01CA248160 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LYSSIOTIS, COSTAS ANDREAS · 2020 to 2024
$2.0M
Targeting metabolic stress to induce pancreatic tumor cell deathR01CA244931 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI LYSSIOTIS, COSTAS ANDREAS · 2020 to 2024
$1.9M
Role of the collagen receptor LAIR-1 in glioma progression and the tumor immune microenvironmentR01NS127378 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Pedro R. Lowenstein · 2022 to 2026
$1.8M
Neuro-immune mechanisms in mutant IDH1 gliomasR37NS144573 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Maria G Castro · 2025 to 2026
$1.3M
Chemo-immunotherapy strategy for pediatric high grade gliomaR21NS123879 · NINDS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI CASTRO, MARIA G, SCHWENDEMAN, ANNA · 2021 to 2021
$429k
NCI NIH HHS P30 CA046592NCI NIH HHS R01 CA244838NCI NIH HHS R01 CA244931NCI NIH HHS R01 CA248160NINDS NIH HHS R01 NS122165NINDS NIH HHS R01 NS122234NINDS NIH HHS R01 NS124167NINDS NIH HHS R01 NS127378NINDS NIH HHS R21 NS123879NINDS NIH HHS R37 NS094804NINDS NIH HHS R37 NS144573
6 · The paper itself

Abstract

Mutant isocitrate dehydrogenase 1 (mIDH1) catalyzes 2-hydroxyglutarate production which leads to epigenetic reprogramming. RNA-seq, scRNA-seq, and ChIP-seq analysis revealed that human and mouse mIDH1 gliomas exhibit downregulated gene ontologies (GOs) related to mitochondrial metabolism and upregulated autophagy-related GOs. Decreased mitochondrial metabolism was accompanied by decreased glycolysis, rendering autophagy a source of energy in mIDH1 gliomas. Human and mouse mIDH1 glioma cells exhibited increased expression of autophagy-related proteins and enhanced LC3 I/II conversion, indicating augmented autophagy. Inhibiting autophagy

Identifiers

PMID40964044
PMCPMC12440097

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.